Researchers have developed PRIDICT2.0 and ePRIDICT, advanced computational tools designed to improve the efficiency of prime editing, a genome edit...
Recent research published in Science Advances has unveiled that what was previously considered 'junk DNA' in the human genome actually plays a sign...
The U.S. cell and gene therapy clinical trials market is anticipated to grow significantly, with projections indicating a market size of USD 14.68 ...
A groundbreaking medical case has been reported where a man with type 1 diabetes successfully produced his own insulin following a gene-edited cell...
Avista Therapeutics, a biotechnology company focused on developing gene therapies for rare ophthalmic conditions, has announced a strategic partner...
Researchers have developed PRIDICT2.0 and ePRIDICT, computational tools designed to improve the efficiency of prime editing, a precise genome editi...
Researchers are advancing CRISPR gene editing trials by employing engineered bacterial nanosyringes for precise genome integrations. These nanosyri...
Researchers at the University of Zurich have developed an AI tool named 'Pythia' to improve the precision of gene editing using CRISPR technology. ...
Researchers at the University of Zurich have developed AI-designed DNA repair templates to improve the precision of gene editing using CRISPR techn...
The field of gene-editing, particularly in human reproduction, is experiencing renewed interest and development. This follows the controversial ann...